Skip to main content

Advertisement

Log in

Antiepileptic drugs and other medications: What interactions may arise?

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Many patients with epilepsy are on lifelong therapy with antiepileptic drugs (AEDs), and AEDs are used for other conditions such as mood stabilization and headache prophylaxis. These drugs have high potential for clinically significant interaction with nonepilepsy drugs. Interactions occur largely through altered pharmacokinetics. One drug may increase the hepatic clearance of another, leading to attenuated efficacy of the affected drug. Alternatively, inhibition of liver metabolism by one drug can cause acute toxicity by reducing clearance of another drug. To identify potential drug interactions before they lead to toxicity or therapy failure, the treating clinician should combine knowledge of the patient’s overall history with a general knowledge of comorbid conditions in which significant interactions involving AEDs are most likely to occur. Treatments susceptible to interactions include anticoagulants, antiarrhythmics, antibiotics, antiretroviral drugs, immunosuppressives, antineoplastics, and contraceptives. Therefore, it is important to obtain periodically a thorough history of medical problems, use of medications or herbal remedies, and adverse effects of medications. Physicians managing epilepsy patients should also strive to avoid potential drug interactions by favoring low-interaction AEDs in patients taking many other types of drugs. There is quite a large degree of patient heterogeneity in the extent of any given interaction between an AED and another drug. Indeed, some groups of patients may have different susceptibilities to such interactions because of genetic and environmental influences on drug metabolism. Effective treatment with AEDs should include attention to drug interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Dickson M, Bramley TJ, Kozma C, et al.: Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients. Am J Health Syst Pharm 2008, 65:1720–1726.

    Article  PubMed  Google Scholar 

  2. Majkowski J, Patsalos PN: Interactions between antiepileptic and non-antiepileptic drugs. In Antiepileptic Drugs: Combination Therapy and Interactions. Edited by Majkowski J, Bourgeois BFD, Patsalos PN, Mattson RH. New York: Cambridge University Press; 2005:139–176.

    Google Scholar 

  3. Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003, 2:473–481.

    Article  PubMed  CAS  Google Scholar 

  4. Perucca E: Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharm 2006, 61:246–255.

    Article  CAS  Google Scholar 

  5. Pollard JR, Delanty N: Antiepileptic drug interactions. Continuum: Epilepsy 2007, 13:91–105.

    Google Scholar 

  6. Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003, 2:347–356.

    Article  PubMed  CAS  Google Scholar 

  7. French JA, Gidal BE: Antiepileptic drug interactions. Epilepsia 2000, 41(Suppl 8):S30–S36.

    Article  PubMed  CAS  Google Scholar 

  8. Krämer G, Tettenborn B, Klosterskov Jensen P, et al.: Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia 1992, 33:1145–1148.

    Article  PubMed  Google Scholar 

  9. Nolan PE Jr, Marcus FI, Karol MD, et al.: Effect of phenytoin on the clinical pharmacokinetics of amiodarone. J Clin Pharmacol 1990, 30:1112–1119.

    PubMed  Google Scholar 

  10. Macphee GJ, McInnes GT, Thompson GG, Brodie MJ: Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet 1986, 1(8483):700–703.

    Article  PubMed  CAS  Google Scholar 

  11. Shorvon SD, Tallis RC, Wallace HK: Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. J Neurol Neurosurg Psychiatry 2002, 72:114–115.

    Article  PubMed  CAS  Google Scholar 

  12. Harden CL, Leppik I: Optimizing therapy of seizures in women who use oral contraceptives. Neurology 2006, 67:S56–S58.

    PubMed  CAS  Google Scholar 

  13. Schwenkhgaen AM, Stodieck SR: Which contraception for women with epilepsy? Seizure 2008, 17:145–150.

    Article  Google Scholar 

  14. Erkkola R, Landgren BM: Role of progestins in contraception. Acta Obset Gynecol Scand 2005, 84:207–216.

    Article  Google Scholar 

  15. Coulam CB, Annegers JF: Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979, 20:519–525.

    Article  PubMed  CAS  Google Scholar 

  16. Reimers A, Helde G, Brodtkorb E: Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005, 46:1414–1417.

    Article  PubMed  CAS  Google Scholar 

  17. Herzog AG, Farina EL, Blum AS: Serum valproate levels with oral contraceptive use. Epilepsia 2005, 46:970–971.

    Article  PubMed  Google Scholar 

  18. Lacerda G, Krummel T, Sabourdy C, et al.: Optimizing therapy of seizures in patients with renal or hepatic dysfunction. Neurology 2006, 67(12 Suppl 4):S28–S33.

    PubMed  CAS  Google Scholar 

  19. Buur-Rasmussen B, Brøren K: Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol 1999, 9:453–459.

    Article  PubMed  CAS  Google Scholar 

  20. Koch-Stoecker S: Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia 2002, 43(Suppl 2):19–24.

    Article  PubMed  Google Scholar 

  21. Desai J: Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobial agents. Epilepsia 2008, 49(Suppl 6):47–49.

    Article  PubMed  Google Scholar 

  22. Kay L, Kampmann JP, Svendsen TL, et al.: Influence of rifampin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol 1985, 20:323–326.

    PubMed  CAS  Google Scholar 

  23. Satishchandra P, Sinha S: Seizures in HIV-seropositive individuals. NIMHANS experience and review. Epilepsia 2008, 49(Suppl 6):33–41.

    Article  PubMed  Google Scholar 

  24. Bhigjee AI, Rosemberg S: Optimizing therapy of seizures in patients with HIV and cysticercosis. Neurology 2006, 67(12 Suppl 4):S19–S22.

    PubMed  CAS  Google Scholar 

  25. Bittencourt PR, Gracia CM, Martins R, et al.: Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 1992, 42(3 Pt 1):492–496.

    PubMed  CAS  Google Scholar 

  26. Mori H, Takahashi K, Mizutani T: Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev 2007, 39:647–657.

    Article  PubMed  CAS  Google Scholar 

  27. Peebles CT, McAuley JW, Roach J, et al.: Alternative medicine use by patients with epilepsy. Epilepsy Behav 2000, 1:74–77.

    Article  PubMed  Google Scholar 

  28. Samuels N, Finkelstein Y, Singer SR, Oberbaum M.: Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008, 49:373–380.

    Article  PubMed  Google Scholar 

  29. Vecht CJ, van Breemen M: Optimizing therapy of seizures in patients with brain tumors. Neurology 2006, 67:S10–S13.

    PubMed  Google Scholar 

  30. Oberndorfer S, Piribauer M, Marosi C, et al.: P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 2005, 72:255–260

    Article  PubMed  CAS  Google Scholar 

  31. Relling MV, Pui CH, Sandlund JT, et al.: Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000, 356:285–290.

    Article  PubMed  CAS  Google Scholar 

  32. Chabolla DR, Wszolek ZK: Pharmacologic management of seizures in organ transplant. Neurology 2006, 67(12 Suppl 4):S34–S38.

    PubMed  CAS  Google Scholar 

  33. Leppik IE: Treatment of epilepsy in the elderly. Curr Treat Options Neurol 2008, 10:239–245.

    Article  PubMed  Google Scholar 

  34. Foldavary-Shaefer N, Wyllie E: Neuropharmacology of the antiepileptic drugs. In Textbook of Clinical Neurology, edn 2. Edited by Goetz CG. New York: Saunders; 2003:1177–1181.

    Google Scholar 

  35. Levy RH, Bourgeois BFD, Hachad H: Drug-drug interactions. In Epilepsy: A Comprehensive Textbook. Edited by Engel J Jr, Pedley TA. Philadelphia: Lippincott Williams & Wilkins; 2008:1235–1248.

    Google Scholar 

  36. Wright JM: Drug interactions. In Melmon and Morrelli’s Clinical Pharmacology: Basic Principles in Therapeutics, edn 4. Edited by Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW. New York: McGraw-Hill; 2000:1257–1266.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John R. Pollard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mani, R., Pollard, J.R. Antiepileptic drugs and other medications: What interactions may arise?. Curr Treat Options Neurol 11, 253–261 (2009). https://doi.org/10.1007/s11940-009-0029-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-009-0029-1

Keywords

Navigation